Q4 2018 G1 Therapeutics Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the G1 Therapeutics Fourth Quarter and Full Year 2018 Financial Results Conference Call. (Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Head of Investor Relations, Jeff Macdonald. Mr. Macdonald, you may begin.
Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics Fourth Quarter and Full Year 2018 Financial Update. Joining me are Mark Velleca, Chief Executive Officer; and Buck Phillips, Chief Financial Officer and Senior Vice President Corporate Development.
Before we begin, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to our filings with the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |